ANVS

Annovis Bio, Inc.

$1.92 +1.05%

Recent alerts on ANVS

All signals →

News Annovis Bio regains NYSE listing compliance

Insider trade Purchase by Hoffman Michael B

News Annovis Bio slips after pricing $15M equity offering

News TSLA, PARA, ANVS, LLY, AMZN: Top 5 Trending Stocks Today - Annovis Bio (NYSE:ANVS), Amazon.com (NASDAQ ... - Benzinga

News CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business

News Novo Nordisk's (NVO) Hypertension Drug Study Fails to Meet Goal

News Dr. Reddy's (RDY) to Acquire Haleon's Nicotine Addiction Drug

News Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

News Cogent (COGT) Up on SUMMIT Study Update Post Positive FDA Meeting

News Bayer's (BAYRY) AskBio Advances Parkinson Disease Study

News Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe

News Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals

News Novo Nordisk (NVO) to Invest $4.1B in Clayton Facility Expansion

News JAZZ Falls as Suvecaltamide Tremor Study Fails to Meet Goals

News Aerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals

News Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals

News Day One (DAWN) In-Licenses MabCare Cancer Candidate, Stock Up

News Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment

News ChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag

News Apellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study

News Halozyme (HALO) Raises 2024 Financial Guidance, Stock Up 13%

News Annexon (ANNX) Up as Phase III Neuro Disorder Study Meets Goals

News Halozyme's (HALO) ENHANZE Product Gets New Patent Grant in EU

News Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag

News AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU

Get push alerts for ANVS

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS